This month’s spotlight is Pediatric Oncology as Contemporary Pediatrics sits down exclusively with pediatric oncologist Lisa Diller, MD, vice chair, Clinical Affairs, and medical director, Clinical Cancer and Blood Disorders Service Line, Dana-Farber Cancer Institute, Boston, Massachusetts, to discuss the one key condition for which she believes community pediatricians should be especially aware—retinoblastoma.
An innovative program helps adolescents and young adults (AYAs) hospitalized with cancer to cope with their disease and navigate their journey through treatment and beyond.
New predictive models may identify and help childhood cancer survivors at a higher risk for ischemic heart disease and stroke.
Adults who have survived childhood cancer are about 10 years ahead of their peers in terms of developing hypertension, according to a new report.
A child’s cancer diagnosis presents psychosocial issues that the community pediatrician needs to assess and treat for the total well-being of the child, siblings, and parents.
The progress in treating cancer in children has been revolutionary, and the evidence base for providing long-term psychosocial care for their families has grown as well.
Pediatricians have had concerns about the known risks of marijuana use in children. What’s next for kids with cancer?
For Contemporary Pediatrics, Dr Bobby Lazzara discusses a large retrospective cohort study published in the Journal of the American Academy of Dermatology that examined whether children with pediatric psoriasis are at increased risk of cancer and discusses 2 caveats to the findings.
A new customized therapy for acute lymphoblastic leukemia (ALL) offers high remission rates but at a substantial cost, and only at specialized cancer centers.
Stratifying tumors by their clinical characteristics and underlying biology will enable future targeting of specific therapies for glioma in children.